699 related articles for article (PubMed ID: 28374129)
1. Dot immunoassay for the simultaneous determination of postvaccination immunity against pertussis, diphtheria, and tetanus.
Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
Anal Bioanal Chem; 2017 Jun; 409(15):3831-3842. PubMed ID: 28374129
[TBL] [Abstract][Full Text] [Related]
2. Diphtheria, tetanus, pertussis: antibody detection in New Zealand.
Lau RC
N Z Med J; 1987 Aug; 100(829):481-3. PubMed ID: 3502676
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of antibodies against diphtheria, tetanus, and pertussis among healthy Thai adolescents.
Hanvatananukul P; Prasarakee C; Sarachai S; Aurpibul L; Sintupat K; Khampan R; Saheng J; Sudjaritruk T
Int J Infect Dis; 2020 Jul; 96():422-430. PubMed ID: 32387447
[TBL] [Abstract][Full Text] [Related]
4. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response.
Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Pourheidari F; Ostadkarampour M; Tavangar B; Shokri F
Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):85-93. PubMed ID: 19671937
[TBL] [Abstract][Full Text] [Related]
5. The maternal antibody against diphtheria, tetanus and pertussis showed distinct regional difference in China.
Meng Q; Qian Q; Li L; Liu D; Gao W; Yuan L; Yao K
BMC Pediatr; 2019 Dec; 19(1):480. PubMed ID: 31810436
[TBL] [Abstract][Full Text] [Related]
6. Immunoblot analysis of humoral immune responses following infection with Bordetella pertussis or immunization with diphtheria-tetanus-pertussis vaccine.
Redd SC; Rumschlag HS; Biellik RJ; Sanden GN; Reimer CB; Cohen ML
J Clin Microbiol; 1988 Jul; 26(7):1373-7. PubMed ID: 2900846
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of magnetic bead pentaplex immunoassay for simultaneous quantification of murine serum IgG antibodies to acellular pertussis, diphtheria and tetanus antigens used in combination vaccines.
Kadam L; Patel K; Gautam M; Thorat S; Kale P; Ghule AK; Gairola A; Rao H; Shinde Y; Shaligram U; Gairola S
Methods; 2019 Apr; 158():33-43. PubMed ID: 30690077
[TBL] [Abstract][Full Text] [Related]
8. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of pertussis, tetanus, and diphtheria antibodies in sera and breast milk from Tdap vaccinated women using a qualified multiplex assay.
Portillo S; Oshinsky J; Williams M; Yoder S; Liang Y; Campbell JD; Laufer MK; Neuzil KM; Edwards KM; Pasetti MF
mSphere; 2024 Apr; 9(4):e0052723. PubMed ID: 38497618
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J
N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705
[TBL] [Abstract][Full Text] [Related]
11. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
[TBL] [Abstract][Full Text] [Related]
12. Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid.
Trollfors B; Taranger J; Lagergård T; Sundh V
Pediatr Infect Dis J; 2005 Jan; 24(1):85-6. PubMed ID: 15665717
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of an antibody against diphtheria, tetanus, and pertussis among the elderly in Khon Kaen, Thailand.
Chinchai T; Posuwan N; Vuthitanachot V; Wanlapakorn N; Poovorawan Y
J Health Popul Nutr; 2019 Oct; 38(1):28. PubMed ID: 31627764
[TBL] [Abstract][Full Text] [Related]
14. [A comparative study of the reactogenicity of pertussis-diphtheria, pertussis-diphtheria-tetanus and adsorbed pertussis-diphtheria-tetanus vaccines].
Sapozhnikov II; Dimova GV; Kotreleva NV; Turchanina AA; Shumova BI
Zh Mikrobiol Epidemiol Immunobiol; 1966 Feb; 43(2):22-7. PubMed ID: 6004848
[No Abstract] [Full Text] [Related]
15. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.
Ladhani SN; Andrews NJ; Southern J; Jones CE; Amirthalingam G; Waight PA; England A; Matheson M; Bai X; Findlow H; Burbidge P; Thalasselis V; Hallis B; Goldblatt D; Borrow R; Heath PT; Miller E
Clin Infect Dis; 2015 Dec; 61(11):1637-44. PubMed ID: 26374816
[TBL] [Abstract][Full Text] [Related]
16. Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal.
Relyveld E; Oato NH; Guérin N; Coursaget P; Huet M; Gupta RK
Vaccine; 1991 Nov; 9(11):843-50. PubMed ID: 1759508
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
[TBL] [Abstract][Full Text] [Related]
18. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
Bernbaum J; Daft A; Samuelson J; Polin RA
Pediatrics; 1989 Apr; 83(4):471-6. PubMed ID: 2538797
[TBL] [Abstract][Full Text] [Related]
19. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
[TBL] [Abstract][Full Text] [Related]
20. An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of age.
Vesikari T; Van Damme P; Lindblad N; Pfletschinger U; Radley D; Ryan D; Vuocolo S; Haupt RM; Guris D
Pediatr Infect Dis J; 2010 Apr; 29(4):314-8. PubMed ID: 19952980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
